TNX102 SL A Promising Treatment for PTSD and Sleep Disorders
Tonix Pharmaceuticals has recently released findings from a study showcasing the effectiveness of bedtime TNX-102 SL in enhancing symptoms of ...
Tag: TNXP
Revolutionizing Fibromyalgia Treatment Tonix Pharmaceuticals and EVERSANA Partner to Launch Tonmya
Tonix Pharmaceuticals has partnered with EVERSANA to develop a comprehensive launch strategy and commercialization plan for Tonmya, a promising treatment ...
Tonix Pharmaceuticals Hosts Webinar on Groundbreaking Fibromyalgia Treatment
On February 14, 2024, Tonix Pharmaceuticals Holding Corp., a renowned biopharmaceutical company, hosted a webinar featuring key opinion leaders (KOLs) ...
Tonix Pharmaceuticals Receives FDA Clearance for Phase 2 OASIS Trial of TNX102 SL for Acute Stress Disorders
On February 12, 2024, Tonix Pharmaceuticals received clearance from the FDA for its Investigational New Drug (IND) application regarding the ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies
